Veracyte, Inc. (VCYT)
VCYT Stock Price Chart
Explore Veracyte, Inc. interactive price chart. Choose custom timeframes to analyze VCYT price movements and trends.
VCYT Company Profile
Discover essential business fundamentals and corporate details for Veracyte, Inc. (VCYT) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Diagnostics & Research
IPO Date
29 Oct 2013
Employees
755.00
Website
https://www.veracyte.comCEO
Marc Stapley
Description
Veracyte, Inc. operates as a diagnostics company in the United States and internationally. The company offers Afirma Genomic Sequencing Classifier for cancerous thyroid nodules; Decipher Prostate Genomic Classifiers for prostate cancer diagnosis; Decipher Bladder Genomic Classifier for bladder cancer diagnosis; Prosigna Breast Cancer Assay for breast cancer diagnosis; and Percepta Nasal Swab Test for lung cancer diagnosis. It also provides the nCounter analysis system services. The company was formerly known as Calderome, Inc. and changed its name to Veracyte, Inc. in March 2008. Veracyte, Inc. was incorporated in 2006 and is headquartered in South San Francisco, California.
VCYT Financial Timeline
Browse a chronological timeline of Veracyte, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 30 Jul 2026
EPS estimate is $0.43, while revenue estimate is $144.59m.
Earnings released on 5 May 2026
EPS came in at $0.52 surpassing the estimated $0.34 by +52.94%, while revenue for the quarter reached $139.07m , beating expectations by +6.68%.
Earnings released on 25 Feb 2026
EPS came in at $0.53 surpassing the estimated $0.41 by +29.81%, while revenue for the quarter reached $140.64m , beating expectations by +3.57%.
Earnings released on 4 Nov 2025
EPS came in at $0.51 surpassing the estimated $0.32 by +59.38%, while revenue for the quarter reached $131.87m , missing expectations by -2.88%.
Earnings released on 6 Aug 2025
EPS came in at $0.44 surpassing the estimated $0.31 by +41.94%, while revenue for the quarter reached $130.16m , beating expectations by +4.67%.
Earnings released on 7 May 2025
EPS came in at $0.31 surpassing the estimated $0.20 by +55.00%, while revenue for the quarter reached $114.47m , beating expectations by +3.16%.
Earnings released on 24 Feb 2025
EPS came in at $0.36 surpassing the estimated $0.10 by +260.00%, while revenue for the quarter reached $118.63m , beating expectations by +7.14%.
Earnings released on 6 Nov 2024
EPS came in at $0.19 surpassing the estimated $0.03 by +603.70%, while revenue for the quarter reached $115.86m , missing expectations by -0.71%.
Earnings released on 6 Aug 2024
EPS came in at $0.30 surpassing the estimated $0.05 by +530.78%, while revenue for the quarter reached $114.43m , beating expectations by +14.12%.
Earnings released on 7 May 2024
EPS came in at -$0.02 surpassing the estimated -$0.19 by +89.47%, while revenue for the quarter reached $96.84m , beating expectations by +3.72%.
Earnings released on 22 Feb 2024
EPS came in at -$0.04 surpassing the estimated -$0.07 by +42.86%, while revenue for the quarter reached $98.20m , beating expectations by +6.78%.
Earnings released on 7 Nov 2023
EPS came in at -$0.03 surpassing the estimated -$0.16 by +81.25%, while revenue for the quarter reached $90.11m , beating expectations by +6.79%.
Earnings released on 8 Aug 2023
EPS came in at -$0.12 surpassing the estimated -$0.16 by +25.00%, while revenue for the quarter reached $90.32m , beating expectations by +8.70%.
Earnings released on 4 May 2023
EPS came in at -$0.11 surpassing the estimated -$0.14 by +21.43%, while revenue for the quarter reached $82.42m , beating expectations by +8.72%.
Earnings released on 22 Feb 2023
EPS came in at -$0.05 surpassing the estimated -$0.15 by +66.67%, while revenue for the quarter reached $80.30m , beating expectations by +8.59%.
Earnings released on 2 Nov 2022
EPS came in at -$0.12 surpassing the estimated -$0.24 by +50.00%, while revenue for the quarter reached $75.59m , beating expectations by +13.83%.
Earnings released on 2 Aug 2022
EPS came in at -$0.13 surpassing the estimated -$0.21 by +38.10%, while revenue for the quarter reached $72.86m , beating expectations by +7.02%.
Earnings released on 3 May 2022
EPS came in at -$0.20 surpassing the estimated -$0.23 by +13.04%, while revenue for the quarter reached $67.78m , beating expectations by +9.48%.
Earnings released on 28 Feb 2022
EPS came in at -$0.15 falling short of the estimated -$0.14 by -7.14%, while revenue for the quarter reached $67.34m , beating expectations by +7.71%.
Earnings released on 9 Nov 2021
EPS came in at -$0.13 surpassing the estimated -$0.14 by +7.14%, while revenue for the quarter reached $60.37m , beating expectations by +12.55%.
Earnings released on 29 Jul 2021
EPS came in at -$0.13 surpassing the estimated -$0.25 by +48.00%, while revenue for the quarter reached $55.11m , meeting expectations.
VCYT Stock Performance
Access detailed VCYT performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.
